Nalaganje...
First case of demyelinating polyneuropathy probably related to treatment with golimumab
Treatment with anti-tumor necrosis factor alpha (anti-TNF α) drugs may lead to demyelinating polyneuropathies. Here, we present the case of a patient with rheumatic disease who developed sensory polyneuropathy probably related to anti-TNF α drugs. The patient was diagnosed with undifferentiated arth...
Shranjeno v:
| izdano v: | Eur J Rheumatol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medical Research and Education Association
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6116850/ https://ncbi.nlm.nih.gov/pubmed/30071941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2018.17193 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|